Primary Uterine Fibroblast Cells; Normal, Human (HUF)-质粒载体-ATCC-DSM-CCUG-泰斯拓生物

你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: 0574-87917803
Primary Uterine Fibroblast Cells; Normal, Human (HUF)
Primary Uterine Fibroblast Cells; Normal, Human (HUF)
规格:
货期:
编号:TS146243
品牌:Testobio
产品名称: Primary Uterine Fibroblast Cells; Normal, Human (HUF)
商品货号: TS146243
Organism: Homo sapiens, human
Tissue: Uterus
Cell Type: Fibroblast
Morphology: Spindleshaped; cells are bipolar and refractile.
Growth Properties: Adherent
Biosafety Level: 1 These primary cells are not known to harbor an agent recognized to cause disease in healthy adult humans. Handle as a potentially biohazardous material under at least Biosafety Level 1 containment. Cells derived from primate lymphoid tissue may fall under the regulations of 29 CFR 1910.1030 Bloodborne Pathogens.xa0

ATCC recommends that appropriate safety procedures be used when handling all primary cells and cell lines, especially those derived from human or other primate material. Detailed discussions of laboratory safety procedures are provided in Laboratory Safety: Principles and Practice, 2nd ed. (ASM Press, Washington, DC) (Fleming et al., 1995) and Caputo, J.L. Biosafety procedures in cell culture. (1988) J. Tissue Culture Methods 11:223. Appropriate safety procedures should always be used with this material. Laboratory safety is discussed in the following publication: Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS Publication No. (CDC) 93-8395. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online at http://www.cdc.gov/biosafety/publications/bmbl5/index.htm.xa0

Human Material Precautionxa0

All tissues used for isolation are obtained under informed consent and conform to HIPAA standards to protect the privacy of the donor’s personal health information. It is best to use caution when handling any human cells. We recommend that all human cells be accorded the same level of biosafety consideration as cells known to carry HIV. With infectious virus assays or viral antigen assays, even a negative test result may leave open the possible existence of a latent viral genome.


Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: Normal
Age: Adult
Gender: Female
Applications: Applications for use might include research related to female reproductive biology; drug testing; and oncology.
Product Format: frozen 1 mL
Storage Conditions: -130°C or below
Comments:

The cells (HUFs) are cryopreserved in the second passage to ensure the highest viability and plating efficiency.xa0

Fibroblast Basal Medium (ATCC PCS-201-030), when supplemented with Fibroblast Growth Kit-Low Serum (ATCC PCS-201-041), provides an ideal system to propagate uterine fibroblasts.

Complete Growth Medium:
  1. Obtain one vial of Primary Uterine Fibroblasts; Normal, Human (TS146243) from the freezer; make sure that the caps of all components are tight.
  2. Thaw the components of the growth kit (ATCC PCS-201-041) just prior to adding them to the basal medium (ATCC PCS-201-030).
  3. Obtain one bottle of Fibroblast Basal Medium-Low Serum (485 mL; PCS-201-041) from cold storage.
  4. Decontaminate the external surfaces of all growth kit component vials and the basal medium bottle by spraying them with 70% ethanol.
  5. Using aseptic technique and working in a laminar flow hood or biosafety cabinet, transfer the indicated volume of each growth kit component, as indicated in Table 1, to the bottle of basal medium using a separate sterile pipette for each transfer.

xa0Table 1. Fibroblast Growth Kit-Low Serum Components

    Component

    Subculturing:

    Volume

    Volume:

    Final Concentration

    Sterility Tests:

    rh FGF b

    Viral Testing:

    0.5 mL

    Viability:

    5 ng/mL

    Population Doubling Capacity:

    L-glutamine

    C of A:

    18.75 mL

首页 > 产品中心 > 微生物培养 > 菌株 > null > Primary Uterine Fibroblast Cells; Normal, Human (HUF)

Primary Uterine Fibroblast Cells; Normal, Human (HUF)

  • 货号: TS146243
  • 好评
有货
  • 品牌 : TESTOBIO
产品名称: Primary Uterine Fibroblast Cells; Normal, Human (HUF)
商品货号: TS146243
Organism: Homo sapiens, human
Tissue: Uterus
Cell Type: Fibroblast
Morphology: Spindleshaped; cells are bipolar and refractile.
Growth Properties: Adherent
Biosafety Level: 1 These primary cells are not known to harbor an agent recognized to cause disease in healthy adult humans. Handle as a potentially biohazardous material under at least Biosafety Level 1 containment. Cells derived from primate lymphoid tissue may fall under the regulations of 29 CFR 1910.1030 Bloodborne Pathogens.xa0

ATCC recommends that appropriate safety procedures be used when handling all primary cells and cell lines, especially those derived from human or other primate material. Detailed discussions of laboratory safety procedures are provided in Laboratory Safety: Principles and Practice, 2nd ed. (ASM Press, Washington, DC) (Fleming et al., 1995) and Caputo, J.L. Biosafety procedures in cell culture. (1988) J. Tissue Culture Methods 11:223. Appropriate safety procedures should always be used with this material. Laboratory safety is discussed in the following publication: Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS Publication No. (CDC) 93-8395. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online at http://www.cdc.gov/biosafety/publications/bmbl5/index.htm.xa0

Human Material Precautionxa0

All tissues used for isolation are obtained under informed consent and conform to HIPAA standards to protect the privacy of the donor’s personal health information. It is best to use caution when handling any human cells. We recommend that all human cells be accorded the same level of biosafety consideration as cells known to carry HIV. With infectious virus assays or viral antigen assays, even a negative test result may leave open the possible existence of a latent viral genome.


Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: Normal
Age: Adult
Gender: Female
Applications: Applications for use might include research related to female reproductive biology; drug testing; and oncology.
Product Format: frozen 1 mL
Storage Conditions: -130°C or below
Comments:

The cells (HUFs) are cryopreserved in the second passage to ensure the highest viability and plating efficiency.xa0

Fibroblast Basal Medium (ATCC PCS-201-030), when supplemented with Fibroblast Growth Kit-Low Serum (ATCC PCS-201-041), provides an ideal system to propagate uterine fibroblasts.

Complete Growth Medium:
  1. Obtain one vial of Primary Uterine Fibroblasts; Normal, Human (TS146243) from the freezer; make sure that the caps of all components are tight.
  2. Thaw the components of the growth kit (ATCC PCS-201-041) just prior to adding them to the basal medium (ATCC PCS-201-030).
  3. Obtain one bottle of Fibroblast Basal Medium-Low Serum (485 mL; PCS-201-041) from cold storage.
  4. Decontaminate the external surfaces of all growth kit component vials and the basal medium bottle by spraying them with 70% ethanol.
  5. Using aseptic technique and working in a laminar flow hood or biosafety cabinet, transfer the indicated volume of each growth kit component, as indicated in Table 1, to the bottle of basal medium using a separate sterile pipette for each transfer.

xa0Table 1. Fibroblast Growth Kit-Low Serum Components

    Component

    Subculturing:

    Volume

    Volume:

    Final Concentration

    Sterility Tests:

    rh FGF b

    Viral Testing:

    0.5 mL

    Viability:

    5 ng/mL

    Population Doubling Capacity:

    L-glutamine

    C of A:

    18.75 mL

合作单位: